Not Signed In - All Topic Areas
1 - 10 of 11 more >>
News
1 - 2 of 2
- Repeated Radioimmunotherapy With 131I-Labetuzumab In Colorectal Cancer With Liver Metastases Found Safe And Well-Tolerated In Initial Phase II Study
MedicalNewsToday - Sat, 03 Jun 2006 06:00 EST
- Zevalin safe and effective for non-Hogdkin's lymphoma patients with advanced disease
MedicalNewsToday - Tue, 17 May 2005 03:00 EST
Clinical Trials
1 - 5 of 47 more >>
- A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
ClinicalTrials.gov Identifier: NCT00435669 - Recruiting
Tumors
- Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003337 - Active, not recruiting
Lymphoma
- Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00195039 - Recruiting
Prostate Cancer
- Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00441571 - Recruiting
Metastatic Prostate Cancer
- Safety and Efficacy Study of FLT Radiolabeled Imaging Agent With PET Scan in Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00572728 - Recruiting
Breast Cancer
email this page
print this page
bookmark this page
feedback on this page
